Approval · Notice of Compliance 2271 · 2001
PUREGON: Notice of Compliance 2271
Issued May 11, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2271
- Date
- May 11, 2001
- Company
- Organon Canada Inc.Kirkland, Quebec, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New multiple dose presentation
- Therapeutic class
- Human gonadotropin
Products in this notice
Medicinal ingredients
- FOLLITROPIN BETA 437 UNIT per CART
- FOLLITROPIN BETA 737 UNIT per CART